139 related articles for article (PubMed ID: 6340249)
1. [Prevention of radiation-induced skin reactions in breast cancer].
Pischnamazzadeh M
Strahlentherapie; 1983 Jan; 159(1):9-12. PubMed ID: 6340249
[TBL] [Abstract][Full Text] [Related]
2. Rutoside and the X-ray induced damage in jejunal mucosa of mouse.
Rao KR; Fritz-Niggli H
Strahlentherapie; 1984 Oct; 160(10):624-6. PubMed ID: 6388050
[TBL] [Abstract][Full Text] [Related]
3. [Reduction of radiation-induced early skin damage (mouse foot) by O-(beta-hydroxyethyl)-rutoside (author's transl)].
Fritz-Niggli H; Fröhlich E
Rofo; 1980 Sep; 133(3):316-21. PubMed ID: 6451559
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of cystoid macular edema with O-beta-hydroxyethyl-rutoside (Venoruton) in a double-blind study].
Artaria LG
Klin Monbl Augenheilkd; 1982 Jun; 180(6):568-70. PubMed ID: 6752553
[No Abstract] [Full Text] [Related]
5. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency.
Bergqvist D; Hallböök T; Lindblad B; Lindhagen A
Vasa; 1981; 10(3):253-60. PubMed ID: 7025500
[No Abstract] [Full Text] [Related]
6. [Reduction of radiation-induced late effects on vascular connective tissue of the skin (mouse paw) by o-(beta-hydroxyethyl)-rutoside].
Fritz-Niggli H; Fröhlich E
Rofo; 1979 May; 130(5):601-8. PubMed ID: 155632
[TBL] [Abstract][Full Text] [Related]
7. Venoruton as a radioprotector: a haematological assessment.
Kanwar KC; Shukla VK; Verma A
Radiobiol Radiother (Berl); 1990; 31(6):517-22. PubMed ID: 2101456
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of O-(beta-hydroxyethyl)-rutosides in the treatment of venous leg ulcers].
Stegmann W; Hubner K; Deichmann B; Muller B
Phlebologie; 1987; 40(1):149-56. PubMed ID: 3554278
[TBL] [Abstract][Full Text] [Related]
9. Rutosides and radiation induced regression of experimental tumours.
Fritz-Niggli H; Rao KR
Arzneimittelforschung; 1977; 27(5):1057-64. PubMed ID: 577871
[TBL] [Abstract][Full Text] [Related]
10. o-(beta-Hydroxyethyl)-rutoside-mediated protection of renal injury associated with cis-diamminedichloroplatinum(II)/hyperthermia treatment.
Bull JM; Strebel FR; Sunderland BA; Bulger RE; Edwards M; Siddik ZH; Newman RA
Cancer Res; 1988 Apr; 48(8):2239-44. PubMed ID: 3349489
[TBL] [Abstract][Full Text] [Related]
11. [Has O-(beta-hydroxyethyl)-rutoside a protective effect in irradiated and non-irradiated tissue? (Models: punch-test on rabbit's ear by Heite and tearing-test on the abdominal skin of the guinea pig].
Klemm J
Arzneimittelforschung; 1970 Jun; 20(6):817-21. PubMed ID: 5468898
[No Abstract] [Full Text] [Related]
12. Effect of HR (O-(beta-hydroxyethyl)-rutosides) on the impaired venous function of young females taking oral contraceptives. A strain gauge plethysmographic and clinical open controlled study.
Forconi S; Guerrini M; Pecchi S; Cappelli R; Bruni F
Vasa; 1980; 9(4):324-30. PubMed ID: 7008418
[TBL] [Abstract][Full Text] [Related]
13. [Dose-response study with O-(beta-hydroxyethyl)-rutoside oral solution].
Nocker W; Diebschlag W
Vasa; 1987; 16(4):365-9. PubMed ID: 3321740
[No Abstract] [Full Text] [Related]
14. [Histochemical and ultrastructural studies on anti-edematous and radiation-protective action of 0-(beta-hydroxyethyl)-rutosides on the rat brain after single irradiation. 2. Histochemical study on carbohydrate metabolism and acid phosphatase activation].
Thiel HJ; Lierse W; Lehmann FM; Sauer R
Strahlenther Onkol; 1988 Nov; 164(11):662-73. PubMed ID: 3201383
[TBL] [Abstract][Full Text] [Related]
15. A double blind trial of oral O. B-hydroxyethyl rutosides for stasis leg ulcers.
Mann RJ
Br J Clin Pract; 1981 Feb; 35(2):79-81. PubMed ID: 7020736
[No Abstract] [Full Text] [Related]
16. Anticatatonic effect of venoruton.
Aley KO; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):263-5. PubMed ID: 2898576
[TBL] [Abstract][Full Text] [Related]
17. [Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases].
ZFA (Stuttgart); 1981 Sep; 57(26):1758-60. PubMed ID: 7303836
[No Abstract] [Full Text] [Related]
18. [Treatment of acute symptoms of hemorrhoid disease with high-dose oral O-(beta-hydroxyethyl)-rutosides].
Annoni F; Boccasanta P; Chiurazzi D; Mozzi E; Oberhauser V
Minerva Med; 1986 Sep; 77(37):1663-8. PubMed ID: 3531924
[TBL] [Abstract][Full Text] [Related]
19. Effect of tri- and tetra-O-(beta-hydroxyethyl)-rutoside on red blood cell aggregation of human blood.
van Haeringen NJ
Bibl Anat; 1975; 13():197-9. PubMed ID: 1231726
[No Abstract] [Full Text] [Related]
20. [Modifications induced by long-term treatment with high doses of 0-(beta-hydroxyethyl)-rutoside in chronic venous insufficiency].
Barbarino C; Pezzangora V
Vasa Suppl; 1989; 27():120. PubMed ID: 2623482
[No Abstract] [Full Text] [Related]
[Next] [New Search]
